Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
33.96
+0.18 (0.53%)
May 30, 2025, 2:45 PM CST
SHA:600329 Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.46B CNY in the quarter ending March 31, 2025, a decrease of -30.22%. This brings the company's revenue in the last twelve months to 6.68B, down -18.12% year-over-year. In the year 2024, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 7.31B, down -11.14%.
Revenue (ttm)
6.68B
Revenue Growth
-18.12%
P/S Ratio
3.42
Revenue / Employee
1.45M
Employees
4,619
Market Cap
22.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.31B | -915.58M | -11.14% |
Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |